Skip to content

Multicenter clinical study of integrated diagnosis of lower respiratory tract infection pathogens and drug resistance based on nanopore sequencing

Multicenter clinical study of integrated diagnosis of lower respiratory tract infection pathogens and drug resistance based on nanopore sequencing

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055304
Enrollment
Unknown
Registered
2022-01-06
Start date
2022-01-06
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low respiratory tract infectoin

Interventions

case series:None

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years. 2. Fever/respiratory symptoms/pulmonary auscultation rales/increased or decreased white blood cells/increased inflammatory markers such as CRP + new lesions confirmed by lung imaging, suspected to be pneumonia; including CAP, HAP/VAP, pneumonia in immunodeficiency patients, etc. 3. Clinicians plan to perform bronchoscopy and bronchoalveolar lavage fluid mNGS to detect pathogens in patients due to clinical diagnosis and treatment needs. 4. The bronchoscopy physician assesses the patient's condition to tolerate bronchoalveolar lavage and obtain adequate bronchoalveolar lavage fluid. 5. The subjects voluntarily participate in this study and sign the informed consent form; if the subjects cannot participate in the informed process, their legal representative must participate in the informed consent process and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The patient refuses to undergo second-generation and third-generation sequencing of bronchoalveolar lavage fluid. 2. Not enough qualified bronchoalveolar lavage fluid specimens were obtained as expected. 3. Those who do not meet the diagnostic criteria for pulmonary infection.

Design outcomes

Primary

MeasureTime frame
pathogen;resistance;

Countries

China

Contacts

Public ContactYu Yunsong
yvys119@zju.edu.cn+86 13805790432

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026